Weight loss drugs may cut cancer risk by 50% according to ‘transformational’ new study
Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment. Now new research out of Israel has found that it can substantially reduce the risk of obesity-related cancers — and it’s more effective … Read more